Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
The Journal of Biological Chemistry
|
April 12, 2001
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor
D G Gilbertson, M E Duff, J W West, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 16, 2021
Maternal serum fructosamine levels and stillbirth: a case-control study of the Stillbirth Collaborative Research Network
E Arslan, A A Allshouse, J M Page, et al.
Arthritis Research & Therapy
|
March 23, 2010
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin
Stacey R Dillon, Brandon Harder, Kenneth B Lewis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
January 29, 2009
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial
M E D'Alton, J Cleary-Goldman, G Lambert-Messerlian, et al.
British Journal of Cancer
|
June 19, 2015
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
M E Gore, C Szczylik, C Porta, et al.
European Journal of Immunology
|
March 19, 2011
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D Levin, David W Taft, Cameron S Brandt, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2007
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F
Rolf E Kuestner, David W Taft, Aaron Haran, et al.
Protein Engineering, Design & Selection : PEDS
|
December 22, 2009
Engineering of stable bispecific antibodies targeting IL-17A and IL-23
Robert Mabry, Katherine E Lewis, Margaret Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†
A Kramar, S Negrier, R Sylvester, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
The Journal of Biological Chemistry
|
April 12, 2001
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor
D G Gilbertson, M E Duff, J W West, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 16, 2021
Maternal serum fructosamine levels and stillbirth: a case-control study of the Stillbirth Collaborative Research Network
E Arslan, A A Allshouse, J M Page, et al.
Arthritis Research & Therapy
|
March 23, 2010
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin
Stacey R Dillon, Brandon Harder, Kenneth B Lewis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
January 29, 2009
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial
M E D'Alton, J Cleary-Goldman, G Lambert-Messerlian, et al.
British Journal of Cancer
|
June 19, 2015
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
M E Gore, C Szczylik, C Porta, et al.
European Journal of Immunology
|
March 19, 2011
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D Levin, David W Taft, Cameron S Brandt, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2007
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F
Rolf E Kuestner, David W Taft, Aaron Haran, et al.
Protein Engineering, Design & Selection : PEDS
|
December 22, 2009
Engineering of stable bispecific antibodies targeting IL-17A and IL-23
Robert Mabry, Katherine E Lewis, Margaret Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†
A Kramar, S Negrier, R Sylvester, et al.
Page
of 16